CA980778A - Pyrimidinones and hydroxy pyrimidines - Google Patents

Pyrimidinones and hydroxy pyrimidines

Info

Publication number
CA980778A
CA980778A CA153,956A CA153956A CA980778A CA 980778 A CA980778 A CA 980778A CA 153956 A CA153956 A CA 153956A CA 980778 A CA980778 A CA 980778A
Authority
CA
Canada
Prior art keywords
pyrimidinones
hydroxy pyrimidines
pyrimidines
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA153,956A
Other languages
English (en)
Other versions
CA153956S (en
Inventor
Christopher A. Lipinski
Gerald G. Deangelis
John G. Stam
Hans-Jurgen E. Hess
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of CA980778A publication Critical patent/CA980778A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CA153,956A 1971-10-29 1972-10-16 Pyrimidinones and hydroxy pyrimidines Expired CA980778A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19400671A 1971-10-29 1971-10-29

Publications (1)

Publication Number Publication Date
CA980778A true CA980778A (en) 1975-12-30

Family

ID=22715935

Family Applications (1)

Application Number Title Priority Date Filing Date
CA153,956A Expired CA980778A (en) 1971-10-29 1972-10-16 Pyrimidinones and hydroxy pyrimidines

Country Status (25)

Country Link
JP (2) JPS5337870B2 (sv)
AR (2) AR198798A1 (sv)
AT (2) AT320656B (sv)
AU (1) AU467600B2 (sv)
BE (1) BE790125A (sv)
CA (1) CA980778A (sv)
CH (2) CH549579A (sv)
DE (3) DE2264374C3 (sv)
DK (1) DK131465B (sv)
EG (1) EG11013A (sv)
ES (2) ES407730A1 (sv)
FI (1) FI55503C (sv)
FR (1) FR2157865B1 (sv)
GB (2) GB1377308A (sv)
IE (1) IE37043B1 (sv)
IL (2) IL40458A (sv)
LU (1) LU66304A1 (sv)
NL (1) NL166470C (sv)
NO (1) NO136574C (sv)
PH (2) PH10129A (sv)
PL (2) PL84634B1 (sv)
SE (2) SE393376B (sv)
SU (2) SU498908A3 (sv)
YU (2) YU35125B (sv)
ZA (1) ZA727362B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151912U (sv) * 1979-04-17 1980-11-01
JPS5752409Y2 (sv) * 1979-11-05 1982-11-15
DE3222914A1 (de) * 1982-06-18 1983-12-22 Beiersdorf Ag, 2000 Hamburg Substituierte 5-phenylthio-6-amino-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
JPH0655686B2 (ja) * 1988-08-30 1994-07-27 宇部興産株式会社 ｐ−ブロモフェノキシアセトアルデヒドジアルキルアセタール類の製造方法
US7776870B2 (en) 2005-08-22 2010-08-17 Melior Pharmaceuticals I, Inc. Methods for modulating Lyn kinase activity and treating related disorders
US8552184B2 (en) 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
US10786503B2 (en) 2017-04-10 2020-09-29 Melior Pharmaceuticals I, Inc. Treatment of adipocytes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2913462A (en) * 1959-11-17 Eahl h
GB951431A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Also Published As

Publication number Publication date
SE393376B (sv) 1977-05-09
DK131465C (sv) 1975-12-08
DE2248741B2 (de) 1974-11-14
AT321308B (de) 1975-03-25
NO136574B (sv) 1977-06-20
DE2248741A1 (de) 1973-05-03
ES407730A1 (es) 1976-01-16
PL89852B1 (sv) 1976-12-31
FR2157865B1 (sv) 1975-10-31
JPS4852780A (sv) 1973-07-24
PL84634B1 (sv) 1976-04-30
AT320656B (de) 1975-02-25
YU99179A (en) 1981-08-31
SU505362A3 (ru) 1976-02-28
SE397090B (sv) 1977-10-17
YU36295B (en) 1982-06-18
DE2264657A1 (de) 1974-06-20
NO136574C (no) 1977-09-28
DK131465B (da) 1975-07-21
PH11594A (en) 1978-03-31
YU255172A (en) 1980-03-15
AR198798A1 (es) 1974-07-24
ZA727362B (en) 1973-11-28
FI55503C (fi) 1979-08-10
AR196263A1 (es) 1973-12-10
EG11013A (en) 1976-11-30
DE2264374A1 (de) 1973-05-24
LU66304A1 (sv) 1973-05-03
IE37043B1 (en) 1977-04-27
ES436624A1 (es) 1977-02-01
SU498908A3 (ru) 1976-01-05
AU4722872A (en) 1974-04-04
DE2264657C2 (de) 1982-09-16
BE790125A (fr) 1973-04-16
IL48790A (en) 1976-05-31
NL7213959A (sv) 1973-05-02
PH10129A (en) 1976-09-02
JPS5337870B2 (sv) 1978-10-12
GB1377308A (en) 1974-12-11
JPS5422995B2 (sv) 1979-08-10
DE2264374B2 (de) 1980-08-07
DE2248741C3 (de) 1975-06-26
FI55503B (fi) 1979-04-30
AU467600B2 (en) 1975-12-04
IE37043L (en) 1973-04-29
JPS53116386A (en) 1978-10-11
IL40458A (en) 1976-05-31
CH555832A (fr) 1974-11-15
GB1377720A (en) 1974-12-18
YU35125B (en) 1980-09-25
FR2157865A1 (sv) 1973-06-08
SE7505279L (sv) 1975-05-06
CH549579A (fr) 1974-05-31
DE2264374C3 (de) 1981-07-23
IL48790A0 (en) 1976-03-31
NL166470B (nl) 1981-03-16
IL40458A0 (en) 1972-11-28
NL166470C (nl) 1981-08-17

Similar Documents

Publication Publication Date Title
CA953071A (en) Panel and lap joint made therefrom
AU466496B2 (en) Pyrimidine derivatives
AU467499B2 (en) Imidazo-diazepines, pyrimidines and imidazoles
CA980778A (en) Pyrimidinones and hydroxy pyrimidines
AU462099B2 (en) Isopropylamino pyrimidine derivatives
AU460810B2 (en) Pyrimidine fungicides
AU3212671A (en) Substituted uracils
CA967964A (en) 2,4-diamino-5-(3,4,5-triethoxybenzyl) pyrimidine
AU4493472A (en) 2-nitroamino-6-hydroxy-4-methyl pyrimidines
CA860327A (en) Arabinofuranosyl pyrimidines
CA860328A (en) Arabinofuranosyl pyrimidines
AU3392171A (en) Cis-zearalenone and cis-zearalenol
AU2676771A (en) Improvements in burners
CA889305A (en) (5-DEOXY-5 PHOSPHORAMIDO-.beta.-D-RIBOFURANOSYL) PURINES AND PYRIMIDINES AND THEIR PREPARATION
CA831985A (en) 2-methoxy-4-(n4-glutarylsulfanilamido) quinazoline
AU458379B2 (en) Trialkoxy quinazolines
AU477979B2 (en) Quinazolinones
CA883833A (en) Pyrimidine derivatives
CA862115A (en) Pyrimidine derivatives
CA887647A (en) 2-amino pyrimidines and their production
CA845721A (en) Chloropyrimidines
CA962272A (en) Pyrimidinones
CA872244A (en) Chloropyrimidine derivatives
CA864555A (en) Arabinofuranosyl pyrimidinone derivative
AU2783271A (en) Trialkoxy quinazolines